Magno-Praxis not only tags and monitors CTCs in the body, a nano-magnetic compound attaches to the cells for eradication. The Magno-Praxis test can capture individual cancer cells that are within 2-30 microns in size. The problem with relying on current imaging systems is that they can only detect tumors of 1mm or greater in size. Ideally Magno-Praxis is used for patients with metastatic (advanced stage) cancers.
The Magno-Praxis therapy is used in conjunction with additional cancer treatments and empowers medical professionals to make decisions that have the best medical outcome for patients.
IV Diagnostics has applied for a Utility patent that is currently in final review.